Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations

Systemic antibodies targeting tumor necrosis factor–α (TNF-α) and interleukin-17A (IL-17A) are effective in plaque psoriasis. Despite their popularity, safety concerns pose a challenge for systemic biologics. While anti–TNF-α and anti–IL-17A antibodies effectively inhibit respective proteins, we hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandal, Abhirup, Kumbhojkar, Ninad, Reilly, Charles, Dharamdasani, Vimisha, Ukidve, Anvay, Ingber, Donald E., Mitragotri, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439648/
https://www.ncbi.nlm.nih.gov/pubmed/32832675
http://dx.doi.org/10.1126/sciadv.abb6049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439648/
https://www.ncbi.nlm.nih.gov/pubmed/32832675
http://dx.doi.org/10.1126/sciadv.abb6049

Ejemplares similares